Cargando…
IGF-IR Targeted Therapy: Past, Present and Future
The IGF-I receptor (IGF-IR) has been studied as an anti-cancer target. However, monotherapy trials with IGF-IR targeted antibodies or with IGF-IR specific tyrosine kinase inhibitors have, overall, been very disappointing in the clinical setting. This review discusses potential reasons why IGF-I R ta...
Autores principales: | Janssen, Joseph A. M. J. L., Varewijck, Aimee J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275034/ https://www.ncbi.nlm.nih.gov/pubmed/25566194 http://dx.doi.org/10.3389/fendo.2014.00224 |
Ejemplares similares
-
Insulin Analogs and Cancer: A Note of Caution
por: Janssen, Joseph A. M. J. L., et al.
Publicado: (2014) -
Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites, IGF-I, and Human Insulin on Insulin and IGF-I Receptor Signaling
por: Varewijck, Aimee J., et al.
Publicado: (2013) -
Parathyroid Imaging: Past, Present, and Future
por: Morris, Michael A., et al.
Publicado: (2022) -
Classification of diabetic retinopathy: Past, present and future
por: Yang, Zhengwei, et al.
Publicado: (2022) -
Modalities for Visualization of Cortical Bone Remodeling: The Past, Present, and Future
por: Harrison, Kimberly D., et al.
Publicado: (2015)